Resources

This strategy is 1 of 5 national strategies that provide a framework for a high-quality and coordinated national response to bloodborne viruses (BBV) and sexually transmissible infections (STI) in Australia.

This Roadmap outlines the investment strategy, rationale and implementation of the Australian Brain Cancer Mission.

As a home care provider, you must include your prices for common Home Care Package services in a pricing schedule. This example shows what’s included in the schedule. You must include a copy of the schedule in all home care agreements.

This report shows results of a 2018 survey of Commonwealth Home Support Program (CHSP) service providers from all states and territories, except Victoria.

The fortnightly Australian Influenza Surveillance Report (AISR) includes information about influenza activity, severity, impact, at-risk populations, virology, and vaccine match and effectiveness. It also gives year-to-date data and comparisons.

This final protocol describes the methodology reviewers will follow to assess use of Life Saving Drugs Program medicines for Pompe disease.

This final protocol describes the methodology reviewers will follow to assess use of Life Saving Drugs Program medicines for MPS II.

This final protocol describes the methodology reviewers will follow to assess use of Life Saving Drugs Program medicines for paroxysmal nocturnal haemoglobinuria.

Australian Government response to the Senate Select Committee on Stillbirth Research and Education Report.

The following spreadsheets provide quarterly 2019 data on childhood immunisation coverage by Primary Health Network (PHN) for all children and Aboriginal and Torres Strait Islander children.

This framework focuses on identifying and understanding medical workforce issues that will benefit from national workforce planning.

This report shows the monthly growth in ACFI subsidies compared to estimates for July 2019.

Use this form to apply for an extension when you are required to handle an SSBA for longer than 2 business days. Please note that this is not required when waiting for the results of confirmatory testing.

Use this form to report changes to the Responsible or Deputy Responsible Officer or their contact details.

Use this form to report changes to your entity or facility details.

Use this form to report changes to the purpose for handling a registered security sensitive biological agent (SSBA), including ceasing a purpose and adding a purpose.

Use this form to report when all of an SSBA is destroyed or the remaining quantity falls below the reportable quantity for a toxin. You can also use this form to de-register. Non-registered facilities that have already provided this information in the relevant form do not have to fill in this form.

Registered facilities should use this form to report an incident that is defined as a reportable event, whether it occurs intentionally or by accident.

Facilities not registered to handle security sensitive biological agents (SSBAs) should use this form to report specific information about SSBAs.

Use this form to report the temporary handling and disposal of a known SSBA (previously confirmed in another facility). Temporary handlings must be for 7 working days or less.

Use this form if you are already a registered facility and want to register a linked storage unit to store Tier 2 SSBAs under Part 4A.5 of the SSBA Standards. To register a new facility, use the Initial Registration form.

Facilities registered to handle security sensitive biological agents (SSBAs) should use this form to report specific information about SSBAs.

Use this form to report the temporary handling and disposal of a known SSBA (previously confirmed in another facility) that you are not registered for. Temporary handlings must be for 7 working days or less.

Use this form for the removal of Salmonella Typhi and Vibrio cholerae.